SAB Biotherapeutics


SAB Biotherapeutics is advancing a new class of immunotherapies with targeted, fully human polyclonal antibodies for the treatment of Covid-19, diabetes, organ transplant & flu.

Industries

Employees

51-200

Links


Org chart

Eddie J. Sullivan
Co-Founder, President & CEO
Collapse
Christoph Bausch
Executive Vice President & Chief Operating Officer
Alexandra Kropotova
EVP, Chief Medical Officer
Lucy To
Chief Financial Officer
Sheila Carlson
Senior Executive Assistant To The CEO
Cindy Sherrill
Senior Director, Office Of The President

Board & advisors

Samuel J. Reich
Chairman & CEO
David Link
Vice Chairman
Christine Hamilton
Co-Founder & Board Member
Eddie Hamilton
Co-Founder, Board Member
Bill Polvino
Board Member
Scott Giberson
Board Member
William J. Polvino
Board Member
Erick Lucera
Director